Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century
Lazzarini PA, Cramb SM, Golledge J, et al.
Diabetologia. Pub. online 13 Dec 2022.
Leggi
MiniMed 780G™ in 2–6-year-old children: safety and clinical outcomes after the first 12 weeks
Pulkkinen MA, Varimo T, Hakonen ET, et al.
Diabetes Technol Ther. Pub. online 13 Dec 2022.
Leggi
GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes
Marx N, Husain M, Lehrke M, et al.
Circulation. 2022;146:1882-1894.
Leggi
Continuous glucose monitoring and metrics for clinical trials: an international consensus statement
Battelino T, Alexander CM, Amiel SA, et al.
The Lancet Diabetes and Endocrinology. Pub. online, 6 December 2022.
Leggi
Initiation of sodium-glucose cotransporter-2 inhibitors at lower HbA1c threshold attenuates eGFR decline in type 2 diabetes patients with and without cardiorenal disease: A propensity-matched cohort study
Cheung JTK, Yang A, Wu H, et al.
Diabetes Res Clin Pract. Pub. online 6 Dec 2022.
Leggi
Two decades of diabetes prevention efforts: a call to innovate and revitalize our approach to lifestyle change
Golovaty I, Ritchie ND, Tuomilehto J, et al.
Diabetes Res Clin Pract. 2022;110195.
Leggi
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
Urva S, Coskun T, Loh MT, et al.
Lancet. 2022;400(10366):1869-1881.
Leggi
Comparison of sodium-glucose cotransporter-2 inhibitor and glucagon-like peptide-1 receptor agonist prescribing in patients with diabetes mellitus with and without cardiovascular disease
Gay HC, Yu J, Persell SD, et al.
Am J Cardiol. 2022;S0002-9149(22)01131-6.
Leggi
Stratifying risk for onset of type 1 diabetes using islet autoantibody trajectory clustering
Mistry S, Gouripeddi R, Raman V, Facelli JC
Diabetologia. 2022 Nov 30.
Leggi
Fully closed-loop insulin delivery in patients undergoing pancreatic surgery
Krutkyte G, Roos J, Schuerch D, et al.
Diabetes Technol Ther. 2022 Nov 30.
Leggi